vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and UNISYS CORP (UIS). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $574.5M, roughly 1.7× UNISYS CORP). UNISYS CORP runs the higher net margin — 3.3% vs 0.7%, a 2.6% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 5.3%). UNISYS CORP produced more free cash flow last quarter ($97.3M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 8.5%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Unisys Corporation is a technology company founded in 1986 and headquartered in Blue Bell, Pennsylvania. The company provides cloud, AI, digital workplace, logistics, and enterprise computing services.
ASTH vs UIS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $574.5M |
| Net Profit | $6.6M | $18.7M |
| Gross Margin | — | 33.9% |
| Operating Margin | 1.9% | 13.3% |
| Net Margin | 0.7% | 3.3% |
| Revenue YoY | 42.9% | 5.3% |
| Net Profit YoY | 184.4% | -37.7% |
| EPS (diluted) | $0.12 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $574.5M | ||
| Q3 25 | $956.0M | $460.2M | ||
| Q2 25 | $654.8M | $483.3M | ||
| Q1 25 | $620.4M | $432.1M | ||
| Q4 24 | $665.2M | $545.4M | ||
| Q3 24 | $478.7M | $497.0M | ||
| Q2 24 | $486.3M | $478.2M | ||
| Q1 24 | $404.4M | $487.8M |
| Q4 25 | $6.6M | $18.7M | ||
| Q3 25 | $373.0K | $-308.9M | ||
| Q2 25 | $9.4M | $-20.1M | ||
| Q1 25 | $6.7M | $-29.5M | ||
| Q4 24 | $-7.8M | $30.0M | ||
| Q3 24 | $16.1M | $-61.9M | ||
| Q2 24 | $19.2M | $-12.0M | ||
| Q1 24 | $14.8M | $-149.5M |
| Q4 25 | — | 33.9% | ||
| Q3 25 | — | 25.5% | ||
| Q2 25 | — | 26.9% | ||
| Q1 25 | — | 24.9% | ||
| Q4 24 | — | 32.1% | ||
| Q3 24 | — | 29.2% | ||
| Q2 24 | — | 27.2% | ||
| Q1 24 | — | 27.9% |
| Q4 25 | 1.9% | 13.3% | ||
| Q3 25 | 2.0% | -7.3% | ||
| Q2 25 | 3.1% | 6.3% | ||
| Q1 25 | 3.3% | 1.2% | ||
| Q4 24 | 0.1% | 8.9% | ||
| Q3 24 | 5.9% | 1.5% | ||
| Q2 24 | 6.2% | 4.9% | ||
| Q1 24 | 7.5% | 3.6% |
| Q4 25 | 0.7% | 3.3% | ||
| Q3 25 | 0.0% | -67.1% | ||
| Q2 25 | 1.4% | -4.2% | ||
| Q1 25 | 1.1% | -6.8% | ||
| Q4 24 | -1.2% | 5.5% | ||
| Q3 24 | 3.4% | -12.5% | ||
| Q2 24 | 3.9% | -2.5% | ||
| Q1 24 | 3.7% | -30.6% |
| Q4 25 | $0.12 | $0.24 | ||
| Q3 25 | $0.01 | $-4.33 | ||
| Q2 25 | $0.19 | $-0.28 | ||
| Q1 25 | $0.14 | $-0.42 | ||
| Q4 24 | $-0.14 | $0.45 | ||
| Q3 24 | $0.33 | $-0.89 | ||
| Q2 24 | $0.40 | $-0.17 | ||
| Q1 24 | $0.31 | $-2.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $413.9M |
| Total DebtLower is stronger | — | $729.0M |
| Stockholders' EquityBook value | $779.3M | $-282.6M |
| Total Assets | $2.2B | $1.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $413.9M | ||
| Q3 25 | $463.4M | $321.9M | ||
| Q2 25 | $342.1M | $300.8M | ||
| Q1 25 | $260.9M | $393.1M | ||
| Q4 24 | $290.8M | $376.5M | ||
| Q3 24 | $350.3M | $373.7M | ||
| Q2 24 | $327.7M | $344.9M | ||
| Q1 24 | $337.3M | $382.8M |
| Q4 25 | — | $729.0M | ||
| Q3 25 | — | $723.2M | ||
| Q2 25 | — | $692.7M | ||
| Q1 25 | — | $488.3M | ||
| Q4 24 | — | $488.2M | ||
| Q3 24 | — | $488.5M | ||
| Q2 24 | — | $489.2M | ||
| Q1 24 | — | $488.4M |
| Q4 25 | $779.3M | $-282.6M | ||
| Q3 25 | $775.5M | $-300.2M | ||
| Q2 25 | $765.5M | $-221.5M | ||
| Q1 25 | $745.4M | $-267.8M | ||
| Q4 24 | $712.7M | $-283.4M | ||
| Q3 24 | $704.6M | $-202.2M | ||
| Q2 24 | $678.9M | $-174.1M | ||
| Q1 24 | $653.5M | $-158.6M |
| Q4 25 | $2.2B | $1.8B | ||
| Q3 25 | $2.2B | $1.7B | ||
| Q2 25 | $1.4B | $1.8B | ||
| Q1 25 | $1.3B | $1.8B | ||
| Q4 24 | $1.4B | $1.9B | ||
| Q3 24 | $1.3B | $1.9B | ||
| Q2 24 | $1.3B | $1.9B | ||
| Q1 24 | $1.2B | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $104.9M |
| Free Cash FlowOCF − Capex | $-6.0M | $97.3M |
| FCF MarginFCF / Revenue | -0.6% | 16.9% |
| Capex IntensityCapex / Revenue | 0.3% | 1.3% |
| Cash ConversionOCF / Net Profit | -0.44× | 5.61× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $-170.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $104.9M | ||
| Q3 25 | $10.0M | $38.0M | ||
| Q2 25 | $90.9M | $-316.2M | ||
| Q1 25 | $16.6M | $33.3M | ||
| Q4 24 | $-10.9M | $76.6M | ||
| Q3 24 | $34.0M | $32.0M | ||
| Q2 24 | $23.2M | $2.7M | ||
| Q1 24 | $6.0M | $23.8M |
| Q4 25 | $-6.0M | $97.3M | ||
| Q3 25 | $7.4M | $32.4M | ||
| Q2 25 | $89.5M | $-324.1M | ||
| Q1 25 | $13.6M | $24.4M | ||
| Q4 24 | $-13.5M | $66.5M | ||
| Q3 24 | $31.7M | $25.2M | ||
| Q2 24 | $20.4M | $-6.0M | ||
| Q1 24 | $5.6M | $17.1M |
| Q4 25 | -0.6% | 16.9% | ||
| Q3 25 | 0.8% | 7.0% | ||
| Q2 25 | 13.7% | -67.1% | ||
| Q1 25 | 2.2% | 5.6% | ||
| Q4 24 | -2.0% | 12.2% | ||
| Q3 24 | 6.6% | 5.1% | ||
| Q2 24 | 4.2% | -1.3% | ||
| Q1 24 | 1.4% | 3.5% |
| Q4 25 | 0.3% | 1.3% | ||
| Q3 25 | 0.3% | 1.2% | ||
| Q2 25 | 0.2% | 1.6% | ||
| Q1 25 | 0.5% | 2.1% | ||
| Q4 24 | 0.4% | 1.9% | ||
| Q3 24 | 0.5% | 1.4% | ||
| Q2 24 | 0.6% | 1.8% | ||
| Q1 24 | 0.1% | 1.4% |
| Q4 25 | -0.44× | 5.61× | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | 2.55× | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
UIS
Segment breakdown not available.
